Stocks Health care DRTS
NASDAQ · Health careAlpha Tau Medical Ltd. (DRTS)
It posted a net loss of $42.6M. In fiscal 2025 capital spending exceeded operating cash flow by $32.8M. At December 31, 2025 it held $12.2M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 9, 2026.
What Alpha Tau Medical Ltd. does
Alpha Tau Medical Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker DRTS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$42.6M | -$0.53 | -$32.8M |
| 2024 | n/a | -$31.8M | -$0.45 | -$22M |
| 2023 | n/a | -$29.2M | -$0.42 | -$24.4M |
| 2022 | n/a | -$33.8M | -$0.53 | -$24.8M |
| 2021 | n/a | -$27.3M | -$0.67 | -$14.7M |
| 2021 | n/a | -$8.9M | -$0.22 | -$11M |
Latest SEC filings
What Alpha Tau Medical Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 31, 2026
- August 10, 2026
- August 10, 2026
- July 21, 2026
- July 15, 2026
- June 25, 2026
- June 23, 2026
- June 11, 2026
- June 3, 2026
- June 1, 2026
Questions about DRTS
What does Alpha Tau Medical Ltd. do?
Alpha Tau Medical Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker DRTS.
Is Alpha Tau Medical Ltd. profitable?
No. In fiscal 2025 it reported a net loss of $42.6M.
When did Alpha Tau Medical Ltd. last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 9, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from August 31, 2026.
Similar companies
Follow DRTS
Get an email when Alpha Tau Medical Ltd. files with the SEC: results, executive changes, material agreements and annual reports.
Follow DRTS: get an email when it filesWhere the numbers come from
Financial figures are the values Alpha Tau Medical Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.